Actively Recruiting
New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies
Led by National and Kapodistrian University of Athens · Updated on 2024-07-29
60
Participants Needed
1
Research Sites
77 weeks
Total Duration
On this page
Sponsors
N
National and Kapodistrian University of Athens
Lead Sponsor
N
National Hellenic Research Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to discover novel biomarkers and therapeutic targets for osteoporosis through the use of advanced omics technologies, including proteomics and metabolomics. By analyzing bone and plasma samples from patients with osteoporosis, the research seeks to understand the underlying mechanisms of the disease and identify potential diagnostic and therapeutic biomarkers.
CONDITIONS
Official Title
New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Postmenopausal Female Patients with osteoporotic subcapital femoral neck fracture (Arm 1)
- Postmenopausal Female Patients with hip osteoarthritis that will undergo Total Hip Replacement (Arm 2)
You will not qualify if you...
- Patients that have undergone before osteoporotic fractures
- Patients with severe cardiovascular, pulmonary, autoimmune, or urinary system conditions
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Laboratory for Research of the Musculoskeletal System
Kifissia, Attica, Greece, 14561
Actively Recruiting
Research Team
E
Efstathios Chronopoulos
CONTACT
S
Stavros Lykos
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here